• 한국식품영양과학회지
• /
• 제34권6호
• /
• pp.892-898
• /
• 2005

본 연구에서는 세계적으로 널리 이용되고 있는 건조 향신료 중 건조생강의 감마선 조사에 의한 휘발성 향기성분의 변화를 관찰하였다. 비조사 건조생강과 10 kGy의 선량으로 조사처리된 건조생강을 SDE방법으로 휘발성 성분 추출후 GC/MS로 분석하였다. 비조사 시료와 조사시료에서 각각 83종, 71종의 화합물이 분리 동정되었으며, 감마선 조사에 따른 뚜렷한 상관관계는 없었다. 건조생강의 주된 향기성분으로는 $\alpha$-zlngiberene, $\beta$-sesquiphellandrene, geranial, (Z, E)-$\alpha$-farnesene, $\beta$-phellandrene으로 이는 조사 처리된 건조생강의 휘발성 향기성분의 조성과 유사함을 알 수 있었다. 방사선 비조사 및 조사 처리된 정유성분의 총량은 각각 $98.27\%$에서 $98.12\%$로$ 0.15\%$ 감소하였으며 monoterpene은 $17.15\%$에서 $17.90\%$로 미량 증가하였으며 , sesquiterpene은 $60.99\%$에서 $61.24\%$로 증가하였다. 반면 oxygenated monoterpene과 oxygenated sesquiterpene은 각각 $0.5\%$와 $0.65\%$ 감소되었다. 성분들 중에서 감마선 조사에 따라 $\alpha$-zingiberene, $\beta$-sesquiphellandrene, geranial, (Z,E)-$\alpha$-farnesenesene, $\beta$-phellandrene등의 합량이 감소됨을 알 수 있었지만 이는 소량으로 감마선 조사가 건조생강의 관능적 요소에 미치는 영향으로 보기는 어렵다.

• 한국식품영양과학회지
• /
• 제42권9호
• /
• pp.1345-1350
• /
• 2013

본 연구는 감귤박의 생리기능성을 탐색하고자 통과 감귤박과, 과피를 제거한 과육 감귤박을 열수와 에탄올로 각각 추출하여 일반성분 및 항산화 활성을 측정하였다. 감귤박의 일반성분을 측정한 결과, 열량과 탄수화물은 통과 감귤박이 더 높았으며 수분은 과육 감귤박이 더 높은 것으로 나타났다. 총 폴리페놀 함량은 추출 용매에 따른 차이는 없었으나, 과피를 포함하고 있는 통과 감귤박이 더 높은 함량을 나타냈다. ESR을 이용한 DPPH 라디칼 소거능과 alkyl 라디칼 소거능 측정 결과, 과육보다는 통과 감귤박의 활성이 더 높았으며, 열수추출물보다는 에탄올추출물이 활성이 높게 측정되었다. Liquid chromatography를 이용한 플라보노이드 함량 분석 결과, naringin은 통과 에탄올추출물에서만 검출되었으며, 또한 nobiletin과 tangeretin의 함량이 통과 에탄올추출물에서 높게 나타났다. GC 분석 결과를 토대로 감귤박 추출물의 항산화 활성은 플라보노이드뿐만 아니라 HMF와 maltol에 기인할 수 있음을 나타냈다. 따라서 과피를 포함하고 있는 통과 감귤박은 기능성 식품을 개발하는 데에 있어서 높은 활용 가치가 있는 것으로 사료된다.

• 대한약침학회지
• /
• 제9권2호
• /
• pp.5-16
• /
• 2006

Objective : It has long been known about the osteogenic effect of CPC-HAS on bone tissues. However, it has not been determined the effect of CPC-HAS on cancer cells. The purpose of this study is to screen the CPC-HAS mediated differentially expressed genes in cancer cells such as HepG2 hepatoma cells. Oligonucleotide microarray and proteomics approaches were employed to screen the differential expression genes. Methods : CPC-HAS was prepared by boiling and stored at $-70^{\circ}C$ until use. Cells were treated with various concentrations of CPC-HAS (0.1, 0.5, 1.5, 10, 20mg/ml) for 24 h. Cell toxicity was tested by MTT assay. To screen the differentially expressed genes in cancer cells, cells were treated with 1.5mg/ml of CPC-HAS. For oligonucleotide microarray assay, total RNA was used for gene expression analysis using oligonucleotide Genechip(Human genome Ul33 Plus 2.0., Affimatrix Co.). For proteomic analysis, total protein was analyzed by 2D gel electrophoresis and Q-TOF mass spectrometer. Results : It has no cytotoxic effects on both HepG2 cell in all concentrations(0.l, 0.5, 1.5, 10, 20mg/ml). In oligonucleotide microarray assay, the number of more than twofold differentially regulated known genes was 23 with 5 up-regulated and 18 down-regulated genes in HepG2 cells. In proteomic analysis, three spots were identified by 2D-gel electrophoresis and Q-TOF analysis. Two down-regulated proteins were aldehyde dehydrogenase 1 and enolase 1, and up-regulated protein was fatty acid binding protein 1 by 1.5mg/ml of CPC-HAS. Discussion : This study showed the screening of CPC-HAS mediated differentially regulated genes using combined approaches of oligonucleotide microarray and proteomic analysis. The screened genes will be used for the better understanding of the therapeutic effects of CPC-HAS on cancer fields.

• Journal of Pharmaceutical Investigation
• /
• 제38권2호
• /
• pp.135-142
• /
• 2008

The present study describes the evaluation of the bioequivalence of two atorvastatin tablets, Lipitor $Tablet^{(R)}$ (Pfizer, reference drug) and Atorva $Tablet^{(R)}$ (Yuhan, test drug), according to the guidelines of Korea Food and Drug Administration (KFDA). Forty-nine healthy male Korean volunteers received each medicine at the atorvastatin dose of 40 mg in a $2{\times}2$ crossover study with a two weeks washout interval. After drug administration, serial blood samples were collected at a specific time interval from 0-48 hours. The plasma atorvastatin concentrations were monitored by an high performance liquid chromatography -tandem mass spectrometer (LC-MS/MS) employing electrospray ionization technique and operating in multiple reaction monitoring (MRM) and positive ion mode. The total chromatographic run time was 4.5 min and calibration curves were linear over the concentration range of 0.1-100 ng/mL for atorvastatin. The method was validated for selectivity, sensitivity, linearity, accuracy and precision. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 48hr) was calculated by the linear log trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were complied trom the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for Atorva $Tablet^{(R)}$ / Lipitor $Tablet^{(R)}$ were ${\log}\;0.9413{\sim}{\log}\;1.0179$ and ${\log}\;0.831{\sim}{\log}\;1.0569$, respectively. These values were within the acceptable bioequivalence intervals of ${\log}\;0.8{\sim}{\log}\;1.25$. Based on these statistical considerations, it was concluded that the test drug, Atorva $Tablet^{(R)}$ was bioequivalent to the reference drug, Lipitor $Tablet^{(R)}$.

• 한국재료학회지
• /
• 제9권3호
• /
• pp.244-250
• /
• 1999

새로운 TiN 선구체인 TEMAT(tertrakis etylmethylamino titanium)과 암모니아를 이용하여 TiN 박막을 형성하였다. 단일 증착원으로 증착시킨 경우에는 $70~1050\AA$/min의 증착률을 얻을 수 있었으며 증착온도에 지배를 받았다. $275^{\circ}C$의 증착온도에서 $0.35\mu\textrm{m}$의 접촉창에서 약 90%의 도포성을 얻을 수 있었다. TEMAT에 암모니아를 첨가하였을 때 단일증착원에서 $3500~6000\mu\omega-cm$정도의 갑을 나타내던 비저상이 ~$800\mu\omega-cm$ 정도로 낮아졌으며 대기중 막의 안정성도 향상되었다. AES의 분석결과에서도 암모니아의 첨가로 현저한 산호와 탄소 함량의 감소를 나타내었다. 그러나 암모니아의 유량을 증가시킬수록 $0.5\mu\textrm{m}$ 접촉창에서 나타난 tiN 박막의 도포성은 감소하였고 이는 TEMAT와 암모니아의 기상 반응에의한 높은 첩착계수를 가진 중간 생성물의 형성에 의한 것으로 생각된다. 반응 부산물에 대한 분석은 QMS에 의해 이루어 졌으며 transamination 반응에 의한 TiN 증착 기구를 제시하였다. 추가적으로 XPS 분석으로 TEMAT와 암모니아의 반응에 의해 만들어지는 탄소는 금소기 탄소였으며 $\beta$-수소 반응이 transamination 반응과 경쟁적으로 일어남을 나타내었다.

• 약학회지
• /
• 제57권1호
• /
• pp.8-17
• /
• 2013

The objective of this study is investigation of contamination levels and transfer rate of heavy metals and assessment of health risk effects in animal medicines. A total of sixteen items with 148 samples were obtained for this investigation from major herbal medicine producing areas and herbal markets from 2011 to 2012. Inductively coupled plasma mass spectrometer method was conducted for the quantitative analysis of Pb, Cd and As. In addition, the mercury analyzer system was conducted for that of Hg without sample digestion. The average contents of heavy metals in animal medicines were as follows : 1.55 mg/kg for Pb, 0.28 mg/kg for Cd, 0.70 mg/kg for As and 0.047 mg/kg for Hg respectively. The average contents of heavy metals in decoctions were as follows : 0.03 mg/kg for Pb, 0.01 mg/kg for Cd, 0.17 mg/kg for As and 0.003 mg/kg for Hg respectively. The average transfer rates of heavy metals from animal medicines to decoctions were 1.9% for Pb, 3.6% for Cd, 24.2% for As and 6.0% for Hg respectively. Cancer risks of animal medicines and decoctions through slope factor by ministry of environment republic korea and environmental protection agency was $1.36{\times}10^{-6}$ and $2.50{\times}10^{-8}$ for Pb and $7.46{\times}10^{-5}$ and $1.98{\times}10^{-5}$ for As (assuming that the total arsenic content was equal to the inorganic arsenic) respectively. The hazard index of heavy metals in animal medicines and decoctions was below recommended hazard index as 0.52 and 0.05 respectively. Taken together, cancer risks about Pb and hazard indexes of animal medicines and decoctions indicate that the majority of samples except for some samples with relative high contents of heavy metals were safe. But cancer risks about As of animal medicines indicate that the majority of samples were not relatively safe.

• 한국식품저장유통학회지
• /
• 제12권4호
• /
• pp.372-378
• /
• 2005

본 연구에서는 우리 나라의 대표적인 향신료 중의 하나인 건고추의 휘발성 유기성분을 n-pentane과 diethylether 혼합용매를 추출용매로 사용하여 연속증류추출장치로 휘발성 유기화합물을 추출하고 이를 GC/MS로 사용하여 분석${\cdot}$확인하였다. 건고추와 조사된 건고추에서 확인된 성분은 각각 61종과 62종으로, 관능기별 상대 면적비는 대체적으로 terpene류, aldehyde류가 두드러지는 경향을 보여 건고추의 주요 휘발성 유기화합물에 크게 영향을 미치는 것으로 판단되었다. 건고추의 대표적인 휘발성 유기화합물로는 furfural, benzaldehyde, linalool, nerolidol, ${\alpha}$-curcumene 및 ${\alpha}$-zingibirene 등이었으며, benzaldehyde와 nerolidol, phenethyl alcohol은 방사선 조사한 후에 감소하였고, furfural과 linalool, ${\alpha}$-zingibirene, ${\alpha}$-curcumene은 방사선 조사한 후에 증가하였다. 특히 1,3-bis[1,1-dimethylethyl]-benzene은 대조군에서는 발견되지 않아 건고추의 방사선 조사여부를 확인하는데 중요한 성분으로 이용가능성이 높을 것으로 판단되었다. 따라서 1,3-bis[1,1-dimethylethyl]-benzene을 방사선 지시물질로 확실하게 판별하기 위해서는 다양한 실험방법을 통한 지속적인 연구가 필요할 것으로 사료된다.

• 보존과학회지
• /
• 제37권5호
• /
• pp.525-535
• /
• 2021

본 연구는 동궁비 원삼의 직금단과 자수에 사용된 금사를 대상으로 과학적 분석을 통해 재료적 특성을 파악하였다. 동궁비 원삼의 금사 배지는 비목질계 섬유소가 관찰되어 닥나무 섬유의 한지를 사용한 것으로 추정된다. XRF 분석을 통해 동궁비 원삼의 통수스란에는 순금의 편금사, 색동과 한삼에는 편은사로 제직한 직금단임을 알 수 있었다. 특히 편은사에서는 황이 높게 검출되는데 이것은 은을 사용하여 금빛을 내기 위한 훈증의 유황 성분의 영향과 보존환경에 의한 황화은이 형성된 것으로 보인다. 또한 용보의 문양은 연금사와 연은사로 표현하였으며, 용보의 테두리는 순금의 연금사로 장식하였다. 특히 본 연구에서는 금사의 금속면과 배지 사이의 접착제와 혼합물에 대해 GC/MS, XRF, Raman 분석을 실시하였다. 그 결과 단백질계 화합물인 아교와 같은 접착제를 사용하고, 혼합물로는 편금사의 경우 활석을 섞고, 편은사에는 석간주를 혼합하여 사용하였음을 확인할 수 있었다.

• Nuclear Engineering and Technology
• /
• 제52권12호
• /
• pp.2860-2866
• /
• 2020

Oxide dispersion-strengthened materials W-1wt%Pr₂O₃ and W-1wt%La₂O₃ were synthesized by wet chemical method and spark plasma sintering. The field emission scanning electron microscopy (FE-SEM) analysis, XRD and Vickers microhardness measurements were conducted to characterize the samples. The irradiations were carried out with a 5 keV helium ion beam to fluences up to 5.0 × 10²¹ ions/m² under 600 ℃ using the low-energy ion irradiation system. Transmission electron microscopy (TEM) study was performed to investigate the microstructural evolution in W-1wt%Pr₂O₃ and W-1wt%La₂O₃. At 1.0 × 10²⁰ He⁺/m², the average loops size of the W-1wt%Pr₂O₃ was 4.3 nm, much lower than W-1wt% La₂O₃ of 8.5 nm. However, helium bubbles were not observed throughout in both doped W materials. The effects of pre-irradiation with 1.0 × 10²¹ He⁺/m² on trapping of injected deuterium in doped W was studied by thermal desorption spectrometry (TDS) technique using quadrupole mass spectrometer. Compared with the samples without He⁺ pre-irradiation, deuterium (D) retention of doped W materials increased after He⁺ irradiation, whose retention was unsaturated at the damage level of 1.0 × 10²²D₂⁺/m². The present results implied that irradiation effect of He⁺ ions must be taken into account to evaluate the deuterium retention in fusion material applications.

• 한국임상수의학회지
• /
• 제36권1호
• /
• pp.46-52
• /
• 2019

Pimobendan has inotropic and vasodilating effects on cardiovascular system, and pentoxifylline is known to decrease blood viscosity and improve blood flow to the heart. This study investigated the pharmacokinetics and pharmacodynamics following oral administration of pimobendan-pentoxifylline powder mixture in dogs. Eight healthy dogs were included and were divided into control (n = 4) and experimental (n = 4) groups. Vehicle powder and pimobendan-pentoxifylline powder mixture (pimobendane 0.25 mg/kg, pentoxifylline 15 mg/kg) were administrated orally to control and experimental groups, respectively. Plasma samples and measurement of echocardiographic indices were obtained for 24 hours following administration. Pimobendan and pentoxifylline concentrations were investigated using liquid chromatography-mass spectrometer (LC-MS) assay. The elimination half-life ($T_{1/2}$) were $2.65{\pm}1.42hours$ for pimobendan and $0.29{\pm}0.23hours$ for pentoxifylline. The time to reach maximum concentration ($T_{max}$) were $1.08{\pm}0.72hours$ for pimobendan and $0.29{\pm}0.14hours$ for pentoxifylline. The maximum blood concentration ($C_{max}$) were $2.83{\pm}1.50ng/mL$ for pimobendan and $1184.33{\pm}932.37ng/mL$ for pentoxifylline. Among echocardiographic indices, fractional shortening (FS), left ventricular internal diameter at end systole (LVIDs), and pre-ejection period (PEP) showed significant changes at 1-4 hours after the administration of pimobendan-pentoxifylline powder mixture. No adverse effects were observed during the investigation. This study demonstrates that pimobendan-pentoxifylline powder mixture can be used to control cardiovascular diseases in dogs.